Fundraising Fox
🦊/Companies
Sign in

Bostoncellstandards

Boston, US · 1 known investors

Find your way into Bostoncellstandards

74 people in our graph share verified history with the Bostoncellstandards team — schools, employers, funds. One of them is your warm intro.

Jai Parekhunlockedknows Seshi Sompuram · together at Boston University School of Medicine (overlapped)
×4knows the team · via Boston University School of Medicine
×7knows the team · via Osmania University

Boston Cell Standards develops calibration and quality-control products (IHCalibrators and IHControls) for immunohistochemistry (IHC) laboratories, used for assay validation, instrument alignment, troubleshooting, and proficiency testing. Its standards serve clinical and research labs and drug developers to maintain consistent IHC test results across sites and trial phases for accurate patient diagnosis and treatment stratification.

BiotechHealthtechMedical Devices

Founders & leadership

SBSteve Bogen MD PhD
Steve Bogen MD PhDinCo-Founder & CEO
KV
Kodela Vani, MSVice President and Co-Founder, Manufacturing
SSSeshi Sompuram
Seshi SompuraminCo-Founder, Co-Inventor & Vice President2003–2025Seshi Sompuram holds a PhD from Boston University School of Medicine, where he also completed postdoctoral training, and serves as Adjunct Assistant Professor of Pathology there. As Co-Founder and VP of R&D at Boston Cell Standards, he contributed to the development and FDA clearance of quantitative immunohistochemistry controls and calibrators; his background includes expertise in molecular biology, antibody engineering, phage-display technology, and cancer diagnostics, with five issued patents and over 45 publications to his name.

Investors · 1

Bantam GroupWestwood

Non-dilutive funding · 12 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2022$385.9K
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2015$1.2M
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$219.2K
National Institutes of Health (NIH)National Institutes of HealthPhase I2011$301.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2008$228.2K
National Institutes of Health (NIH)National Institutes of HealthPhase I2008$145.7K
National Institutes of Health (NIH)National Institutes of HealthPhase I2007$100K
National Institutes of Health (NIH)National Institutes of HealthPhase II2006$1.1M
National Institutes of Health (NIH)National Institutes of HealthPhase II2004$863.4K
National Institutes of Health (NIH)National Institutes of HealthPhase I2004$225.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Bostoncellstandards do?
Boston Cell Standards develops calibration and quality-control products (IHCalibrators and IHControls) for immunohistochemistry (IHC) laboratories, used for assay validation, instrument alignment, troubleshooting, and proficiency testing. Its standards serve clinical and research labs and drug developers to maintain consistent IHC test results across sites and trial phases for accurate patient diagnosis and treatment stratification.
Who founded Bostoncellstandards?
Bostoncellstandards was founded by Steve Bogen MD PhD, Kodela Vani, MS, Seshi Sompuram.
Who are Bostoncellstandards's investors?
Bostoncellstandards's investors include Bantam Group.
Where is Bostoncellstandards headquartered?
Bostoncellstandards is headquartered in Boston, US.